We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Microparticles Coated with Apoptotic Antigens Blunt Autoimmune Attack

By LabMedica International staff writers
Posted on 29 Nov 2012
The molecular processes responsible for autoimmune diseases such as multiple sclerosis (MS) can be shut down by exposing cells in the immune system to microparticles coated with antigens from cells that have been reduced to fragments by apoptosis.


Investigators at Northwestern University (Chicago, IL, USA) had previously shown that antigen-bound apoptotic cells could be injected safely into patients with MS. More...
While this treatment induced T cell tolerance that prevented further autoimmune attack and slowed progression of the disease, it was not practical for routine clinical use. Senior author Dr. Stephen Miller, professor of immunology at Northwestern University, explained, "Cellular therapy is extremely expensive as it needs to be carried out in a large medical center that has the capability to isolate patient's white blood cells under sterile conditions and to re-infuse those antigen-coupled cells back into the patients. It is a costly, difficult, and time-consuming procedure."

A search for alternative methods to replace living cells as transporters of apoptotic antigens led to the development of suitable synthetic microparticles. In a paper published in the November 18, 2012, online edition of the journal Nature Biotechnology the investigators described the preparation of polystyrene or biodegradable poly(lactide-co-glycolide) microparticles coated with antigens relevant to a mouse model of MS (relapsing experimental autoimmune encephalomyelitis).

Mice with relapsing experimental autoimmune encephalomyelitis were treated by intravenous infusion of the microparticles. Results showed that treatment with the microparticles prevented the onset and modified the course of the disease. These beneficial effects required microparticle uptake by marginal zone macrophages expressing the scavenger receptor MARCO and were mediated in part by the activity of regulatory T cells, abortive T-cell activation, and T-cell anergy.

The biodegradable poly(lactide-co-glycolide) used to formulate the microparticles has already been approved by the [US] Food and Drug Administration and is currently used in sutures as well as in clinical trials to deliver anticancer agents. Dr. Miller said, "I think we have come up with a very potent way to induce tolerance that can be easily translated into clinical practice. We are doing everything we can now to take this forward."

Related Links:

Northwestern University




New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
Alcohol Testing Device
Dräger Alcotest 7000
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Microbiology

view channel
Image: The groundbreaking salmonella antimicrobial resistance prediction platform has demonstrated 95% accuracy (Photo courtesy of Yujie You et al., DOI: 10.1016/j.eng.2025.01.013)

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance

Antimicrobial-resistant Salmonella strains are a growing public health concern due to the overuse of antimicrobials and the rise of genetic mutations. Accurate prediction of resistance is crucial for effective... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.